Font Size: a A A
Keyword [Convertase]
Result: 41 - 60 | Page: 3 of 3
41. Characterization of Complement C3 Dysregulation Predisposing to Two Human Disease States
42. Expression and transient nuclear translocation of protein convertase 1 (PC1) during mouse preimplantation embryonic development
43. Decreased expression of prohormone convertase I and II contributes to adult onset obesity in Nhlh2 knockout mice
44. ANGIOTENSIN CONVERTING ENZYME IN THE BRAIN, TESTIS, EPIDIDYMIS, PITUITARY GLAND AND ADRENAL GLAND (CAPTOPRIL, EUKEPHALIN CONVERTASE, PEPTIDASE, CORPUS STRIATUM, GUANIDINOETHYL MERCAPTOSUCCINIC ACID)
45. Melatonin Inhibits Pyroptosis Of Vascular Endothelial Cells And Antiatherosclerosis Through The Circ?0000033/miR-214-3p/PCSK9 Pathway
46. Chinese Familial Hypercholesterolemia Clinical Series
47. Changes And Clinical Significance Of Serum PCSK9 Level In Patients With Type 2 Diabetic Peripheral Neuropathy
48. PCSK9 Expression Changes In PCOS Ovarian Tissues And Its Effect On Lipid Uptake Of KGN Cells
49. Nicotinamidemononucleotide Improves Hypercholesterolemia Throughthe HNF-1?/PCSK9/LDLR Pathway
50. High Glucose Upregulates PCSK9 Expression And Increases Lipid Accumulation Via Promotion Of N-linked Glycosylation Of SCAP
51. Expression Of Secretory Protein PC6 In Endometrium Of Recurrent Implantation Failure
52. Role Of PCSK9 In Acute Ischemic Stroke And Parkinson's Disease
53. Effects Of Pro-protein Convertase Subtilisin/kexin 9 On Intestinal Tumor In ApcMin/+ Mice
54. Correlation Between Plasma PCSK9 And Coronary Artery Disease In Patients With Coronary Heart Disease
55. Study On The Expression Of Serum ABCA1,Hcy And PCSK9 In Patients With Coronary Heart Disease
56. The Effect Of Evolocumab On Lipid Levels,Glucose And Liver And Kidney Functions In Patients With Very High-risk ACS
57. Study On The Lipid-lowering Effect Of Evolocumab In Patients With Acute Coronary Syndrome
58. Meta-Analysis Of The Lipid-Lowering Efficacy And Cardiovascular Safety Of PCSK9 Inhibitors With ACS
59. Study On Generation Of Rabbit Models Of Cardiovascular Disease Caused By Point Mutation In PCSK9 And CBS Using CRISPR/Cas9
60. Research On A New Method For Quantitative Analysis Of PCSK9 In Serum Based On ECL Technology
  <<First  <Prev  Next>  Last>>  Jump to